Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Aug 8 - Aug 13
Convenient DosingSimple scoop-and-mix format ensures precise and easy daily supplementation
Directions: Consume two gummies per day
Tirzepatide (a GLP-1R/GIPR dual agonist), licensed by the MHRA as Mounjaro for type 2 diabetes and, subject to NICE guidance, for weight management in adults with obesity, achieved mean weight reductions of up to approximately 22% in the SURMOUNT-1 trial (NEJM 2022) a notable improvement over GLP-1R monotherapy
For patients with chronic kidney disease, heart failure, or established atherosclerotic cardiovascular disease, substituting a sodium-glucose cotransporter 2 (SGLT2) inhibitor may be preferred
Age-related factors, our genetics, and our environment can slow the metabolism, which impacts many aspects of our overall health, including the following
The x-axis denotes base position in reads, while the y-axis displays the percentage of each base type, with Read 1 and Read 2 delineated by a dashed vertical line
US$ 25.81
US$ 24.72
US$ 24.89
US$ 29.39
US$ 21.05
US$ 23.90
US$ 24.96
US$ 24.71
